KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,595,295 | +16.6% | 206,983 | -5.5% | 0.00% | 0.0% |
| Q2 2023 | $3,084,745 | +31.6% | 219,087 | +0.6% | 0.00% | 0.0% |
| Q1 2023 | $2,344,464 | -23.9% | 217,887 | +6.0% | 0.00% | 0.0% |
| Q4 2022 | $3,079,244 | +17.3% | 205,557 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $2,626,000 | +224.2% | 204,500 | +144.9% | 0.00% | – |
| Q2 2022 | $810,000 | +5.6% | 83,503 | +8.3% | 0.00% | – |
| Q1 2022 | $767,000 | -14.8% | 77,082 | +0.8% | 0.00% | – |
| Q4 2021 | $900,000 | +6.5% | 76,456 | +3.1% | 0.00% | – |
| Q3 2021 | $845,000 | -13.8% | 74,170 | +5.5% | 0.00% | – |
| Q2 2021 | $980,000 | -19.1% | 70,296 | +7.4% | 0.00% | – |
| Q1 2021 | $1,212,000 | +4.2% | 65,446 | -0.6% | 0.00% | – |
| Q4 2020 | $1,163,000 | +15.1% | 65,815 | -0.2% | 0.00% | – |
| Q3 2020 | $1,010,000 | -15.8% | 65,921 | +40.1% | 0.00% | -100.0% |
| Q2 2020 | $1,199,000 | +118.0% | 47,047 | +32.5% | 0.00% | – |
| Q1 2020 | $550,000 | +63.2% | 35,496 | +16.6% | 0.00% | – |
| Q4 2019 | $337,000 | +8.7% | 30,440 | -16.4% | 0.00% | – |
| Q3 2019 | $310,000 | -36.5% | 36,404 | +1.1% | 0.00% | – |
| Q2 2019 | $488,000 | +12.4% | 36,013 | +50.1% | 0.00% | – |
| Q1 2019 | $434,000 | +3.6% | 23,992 | +61.0% | 0.00% | – |
| Q4 2018 | $419,000 | +10.3% | 14,900 | 0.0% | 0.00% | – |
| Q3 2018 | $380,000 | – | 14,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |